Table 2 The demographics of all subjects

From: The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring

Groups

Age (years)

Males (%)

Year of onset

Healthy controls

37.0±7.3

18 (36.0%)

 

Patients

36.8±10.7

15 (38.9%)

28.4±10.3

  1. Ages were mean±s.d.
Back to article page